MXAClass II
System, Test, Breath Nitric Oxide
21 CFR 862.3080 / Clinical Toxicology
MXA is the FDA product code for System, Test, Breath Nitric Oxide, a class II device type, regulated under 21 CFR 862.3080. As of , FDA records hold 15 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- MXA
- Device name
- System, Test, Breath Nitric Oxide
- Regulation
- 21 CFR 862.3080
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 15
- Ingested recalls
- 1
Clearances, product code MXA
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2003 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Applicants with the most clearances
Product code MXA| Applicant | Clearances |
|---|---|
| Aerocrine AB | 6 |
| Apieron, Inc. | 2 |
| Bosch Healthcare Solutions GmbH | 2 |
| Bedfont Scientific Ltd. | 1 |
| Caire Diagnostics, Inc. | 1 |
| Circassia AB | 1 |
| Mgc Diagnostics Corporation | 1 |
| Spirosure, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
